Literature DB >> 33086435

The therapy with icosapent ethyl after the EVAPORATE trial: Between hope and skepticism.

Marijana Tadic1, Cesare Cuspidi2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33086435      PMCID： PMC8029848          DOI： 10.1111/jch.14082

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  11 in total

1.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Authors:  Deepak L Bhatt; P Gabriel Steg; Michael Miller; Eliot A Brinton; Terry A Jacobson; Steven B Ketchum; Ralph T Doyle; Rebecca A Juliano; Lixia Jiao; Craig Granowitz; Jean-Claude Tardif; Christie M Ballantyne
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

2.  Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.

Authors:  Sang-Eun Lee; Hyuk-Jae Chang; Ji Min Sung; Hyung-Bok Park; Ran Heo; Asim Rizvi; Fay Y Lin; Amit Kumar; Martin Hadamitzky; Yong Jin Kim; Edoardo Conte; Daniele Andreini; Gianluca Pontone; Matthew J Budoff; Ilan Gottlieb; Byoung Kwon Lee; Eun Ju Chun; Filippo Cademartiri; Erica Maffei; Hugo Marques; Jonathon A Leipsic; Sanghoon Shin; Jung Hyun Choi; Kavitha Chinnaiyan; Gilbert Raff; Renu Virmani; Habib Samady; Peter H Stone; Daniel S Berman; Jagat Narula; Leslee J Shaw; Jeroen J Bax; James K Min
Journal:  JACC Cardiovasc Imaging       Date:  2018-06-13

3.  Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

4.  Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.

Authors:  Matthew J Budoff; Joseph B Muhlestein; Deepak L Bhatt; Viet T Le Pa; Heidi T May; Kashif Shaikh; Chandana Shekar; April Kinninger; Suvasini Lakshmanan; Sion K Roy; John Tayek; John R Nelson
Journal:  Cardiovasc Res       Date:  2021-03-21       Impact factor: 10.787

5.  Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.

Authors:  Theingi Aung; Jim Halsey; Daan Kromhout; Hertzel C Gerstein; Roberto Marchioli; Luigi Tavazzi; Johanna M Geleijnse; Bernhard Rauch; Andrew Ness; Pilar Galan; Emily Y Chew; Jackie Bosch; Rory Collins; Sarah Lewington; Jane Armitage; Robert Clarke
Journal:  JAMA Cardiol       Date:  2018-03-01       Impact factor: 14.676

6.  Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.

Authors:  Donghee Han; Daniel S Berman; Robert J H Miller; Daniele Andreini; Matthew J Budoff; Filippo Cademartiri; Kavitha Chinnaiyan; Jung Hyun Choi; Edoardo Conte; Hugo Marques; Pedro de Araújo Gonçalves; Ilan Gottlieb; Martin Hadamitzky; Jonathon Leipsic; Erica Maffei; Gianluca Pontone; Sangshoon Shin; Yong-Jin Kim; Byoung Kwon Lee; Eun Ju Chun; Ji Min Sung; Sang-Eun Lee; Renu Virmani; Habib Samady; Peter Stone; Jagat Narula; Jeroen J Bax; Leslee J Shaw; Fay Y Lin; James K Min; Hyuk-Jae Chang
Journal:  JAMA Netw Open       Date:  2020-07-01

7.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2020-02-29

8.  Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.

Authors:  Eliot A Brinton; Christie M Ballantyne; John R Guyton; Sephy Philip; Ralph T Doyle; Rebecca A Juliano; Lori Mosca
Journal:  J Womens Health (Larchmt)       Date:  2018-03-27       Impact factor: 2.681

9.  High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk.

Authors:  Peter P Toth; Craig Granowitz; Michael Hull; Djibril Liassou; Amy Anderson; Sephy Philip
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

10.  Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.

Authors:  Matthew J Budoff; Deepak L Bhatt; April Kinninger; Suvasini Lakshmanan; Joseph B Muhlestein; Viet T Le; Heidi T May; Kashif Shaikh; Chandana Shekar; Sion K Roy; John Tayek; John R Nelson
Journal:  Eur Heart J       Date:  2020-10-21       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.